DERIVATIVE FINANCIAL INSTRUMENTS	12 Months Ended
Dec. 30, 2022
DERIVATIVE FINANCIAL INSTRUMENTS
DERIVATIVE FINANCIAL INSTRUMENTS	4. DERIVATIVE FINANCIAL INSTRUMENTS On January 31, 2019, the Company entered into an interest rate swap agreement that the Company designated as cash flow hedge to fix the variable interest rate on a portion of the Company’s Term A Loan (as defined below in Note 5. “Debt Obligations”). The interest rate swap agreement had a total notional amount of $35.0 million and had a fixed annual interest rate of 2.47%. The interest rate swap expired on January 31, 2022. At its expiration, fiscal year 2022 changes in the fair value of the Company’s interest rate swap agreement were immaterial to the Company’s consolidated financial statements and were included in accrued liabilities in the Company’s consolidated balance sheet. At its expiration, the effective portion of the Company’s interest rate swap agreement designated as a cash flow hedge for fiscal year 2022 was immaterial to the Company’s consolidated financial statements, and all amounts were reclassified from accumulated other comprehensive income to interest expense. As of December 30, 2022, the Company had no derivative financial instruments in place.

DERIVATIVE FINANCIAL INSTRUMENTS

12 Months Ended

Dec. 30, 2022

4. DERIVATIVE FINANCIAL INSTRUMENTS

On January 31, 2019, the Company entered into an interest rate swap agreement that the Company designated as cash flow hedge to fix the variable interest rate on a portion of the Company’s Term A Loan (as defined below in Note 5. “Debt Obligations”). The interest rate swap agreement had a total notional amount of $35.0 million and had a fixed annual interest rate of 2.47%. The interest rate swap expired on January 31, 2022.

At its expiration, fiscal year 2022 changes in the fair value of the Company’s interest rate swap agreement were immaterial to the Company’s consolidated financial statements and were included in accrued liabilities in the Company’s consolidated balance sheet.

At its expiration, the effective portion of the Company’s interest rate swap agreement designated as a cash flow hedge for fiscal year 2022 was immaterial to the Company’s consolidated financial statements, and all amounts were reclassified from accumulated other comprehensive income to interest expense.

As of December 30, 2022, the Company had no derivative financial instruments in place.